Yongkai Li

Yongkai Li is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as Associate Director at Genesis Therapeutics since September 2022. Prior to this role, Yongkai held the position of Associate Director at Zentalis Pharmaceuticals from May 2021 to June 2022. Additionally, Yongkai was a Principal Investigator at Calibr at Scripps Research from January 2020 to May 2021 and worked as a Research Investigator at the Genomics Institute of the Novartis Research Foundation from April 2007 to December 2019. Early career experience includes roles as a Research Scientist at Ligand Pharmaceuticals and as a Postdoc at The Scripps Research Institute. Yongkai Li's academic background includes education from Dartmouth College and Nanjing University.